About
About Us
Leadership
Scientific Advisory Board
Locations
Development History
Awards
Investor
Announcements
Stock Trend
Investor Interaction
ESG
ESG Concept
ESG Policy
Media Center
Video Center
Image Center
Product & Services
API & Intermediate
Portfolio
R&D
Patents
CDMO
One-Stop Service
Platforms
Capacity
Finished Dosage Form
Product Service
R&D
Aesthetic & Care Ingredients
Portfolio
R&D
Technology Platforms
DS Technology Platforms
Flow Chemistry
Synthetic Biology & Biocatalysis
Crystallization & Particle Engineering
Peptide
High Potency Compound
Conjugate Library Service
Oligonucleotide Synthesis
Preparation & Purification
DP Technology Platforms
Controlled-release Formulation Development
Taste Masking Technology
Particle Flow Simulation
Technical Support Centers
Analytical Testing Center
Process Safety Center
News
Events
News Room
Careers
Join Us
Meet our People
Talent Strategy
Working at Apeloa
CN
Contact Us
About
About Us
Leadership
Scientific Advisory Board
Locations
Development History
Awards
Investor
Announcements
Stock Trend
Investor Interaction
ESG
ESG Concept
ESG Policy
Media Center
Video Center
Image Center
Product & Services
API & Intermediate
Portfolio
R&D
Patents
CDMO
One-Stop Service
Platforms
Capacity
Finished Dosage Form
Product Service
R&D
Aesthetic & Care Ingredients
Portfolio
R&D
Technology Platforms
DS Technology Platforms
Flow Chemistry
Synthetic Biology & Biocatalysis
Crystallization & Particle Engineering
Peptide
High Potency Compound
Conjugate Library Service
Oligonucleotide Synthesis
Preparation & Purification
DP Technology Platforms
Controlled-release Formulation Development
Taste Masking Technology
Particle Flow Simulation
Technical Support Centers
Analytical Testing Center
Process Safety Center
News
Events
News Room
Careers
Join Us
Meet our People
Talent Strategy
Talent Development
Talent Policy
Working at Apeloa
Contact Us
CN
Sitemap
Home
Home
About
About us
Leadership
Scientific advisory board
Locations
Development History
Awards
Product & Services
API & Intermediate
CDMO
Finished Dosage Form
Aesthetic & Care Ingredients
Technology Platforms
DS Technology Platforms
Flow Chemistry
Synthetic Biology & Biocatalysis
Crystallization & Particle Engineering
Peptide
High Potency Compound
Conjugate Library Service
Oligonucleotide Synthesis
Preparation & Purification
DP Technology Platforms
Controlled-release Formulation Development
Taste Masking Technology
Particle Flow Simulation
Technical Support Centers
Analytical Testing Center
Process Safety Center
News
Events
CPHI Japan 2025
in-cosmetics Global 2025
APS Seminar & Party
DCAT Week 2025
BioEurope Spring 2025
2025 SAPA-GP Annual Conference
53rd Organic Process Research and Development Conference
TIDES Asia 2025
PCHi 2025
15th COSME Week Tokyo
43rd Annual J.P. Morgan Healthcare Conference
CPHI Middle East 2024
41st Medicinal Chemistry Symposium
BioEurope 2024
15th World ADC Conference
CPHI Milan 2024
CBA Annual Conference 2024
SAPA 2024 Annual Conference
23rd Contract Pharma Conference & Tabletop Exhibition
52nd Organic Process Research and Development Conference
ChemOutsourcing 2024
2nd Annual ADC Linker and Conjugation Summit
CBA-China 2024
CPHI China 2024
Chemspec Europe 2024
CPHI North America 2024
12th Annual Advances in Chemical Sciences Symposium
DCAT Week 2024
51st Organic Process Research & Development Conference
6th Flow Chemistry and Continuous Processing Conference
News Room
APELOA proudly introduces our latest API product, Gabapentin
APELOA has obtained FDA approval for Amantadine Hydrochloride Tablets (100mg)
Grand Opening of the Apeloa Pharma Solutions R&D Center in Billerica, MA
Dr. Yong-Li Zhong as Chief Technology Officer, Chemistry
2024 Interim Report Highlights
APELOA has obtained FDA approval for our Metoprolol Succinate Extended-Release Tablets
Apeloa is among the Top 5 in the China Pharmaceutical CDMO Companies
Dr. Johannes Platzek as Chief Scientific Officer of APELOA CDMO BU
We are proud to announce that Apeloa has received the "API Development & Innovation Award" and the "Premium Global Partner" award at CPHI China 2024!
Hasten Biopharmaceutical Forms Strategic Partnership with Apeloa Pharmaceutical to Enhance Healthcare Innovation
Innovation Milestone: Apeloa Pharmaceutical CDMO Global Service Platform Ready for Use, Pharmaceutical Manufacturing Innovation Forum Held
Careers
Join us
Meet our People
Talent Strategy
Working at Apeloa
We value your privacy
To enhance user experience and protect your rights and privacy, please review our
Privacy Policy
and
Legal Statement
. By clicking "Accept All", you acknowledge and accept the above terms.
Reject All
Accept All